Navigation Links
Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals
Date:5/28/2010

DUBLIN, May 28, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. ("Zydus") advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).

LIALDA is protected by the following FDA Orange Book listed patent: U.S. Patent No. 6,773,720, Mesalazine Controlled Release Pharmaceutical Compositions (the "'720 patent"). The patent expires in 2020.

Shire is currently reviewing the details of Zydus' Paragraph IV Notice Letter. Under the Hatch-Waxman Act, Shire has 45 days from the receipt of the Notice Letter to determine if it will file a patent infringement suit. If Shire brings suit pursuant to the Hatch Waxman regulations, a stay of approval of up to 30-months will be imposed by the FDA on Zydus' ANDA.

Notes to Editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of produ
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... CHESTER, Pa. , Sept. 19, 2014 /PRNewswire/ ... launched two new variable angle plating systems featuring ... technology, surgeons can adapt screw trajectory to match ... towards specific fragments of bone. The systems are ... Foot & Ankle Society (AOFAS) and the International ...
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- ... to 2020″, provides key market data ... devices market. The report provides value, ... volume (in units) within market categories ... Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, ...
(Date:9/19/2014)... , Sept. 19, 2014  For Cloud ... drug design and development, partnering is an integral ... is to design new drugs and identify early ... partners to further their development. The company also ... To support this business model, Cloud Pharmaceuticals will ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... 2010 Zimmer Holdings, Inc. (NYSE: ZMH ... today announced it has acquired Sodem Diffusion S.A., the ... Geneva, Switzerland.  The company will be re-named Zimmer Surgical, ... in Dover, Ohio.   "Adding SoPlus,s innovative ...
... 22, 2010 Watson Pharmaceuticals (NYSE: WPI ) ... of a novel oral contraceptive product – the first and ... and 0.025 mg ethinyl estradiol in chewable form, with four ... daily, the product is proven effective in lowering ...
Cached Medicine Technology:Zimmer Announces Acquisition of SoPlus Orthopaedic Surgical Power Tools Company 2Watson Announces Novel Oral Contraceptive Approval 2Watson Announces Novel Oral Contraceptive Approval 3Watson Announces Novel Oral Contraceptive Approval 4
(Date:9/22/2014)... Steven Reinberg HealthDay Reporter ... that bacterial pneumonia can raise your risk of heart problems, ... and kill heart cells, increasing the chances of heart failure, ... report. In mice, monkeys and human heart tissue, researchers ... and they tried a vaccine that might one day prevent ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 At ... the nonprofit Seafood Nutrition Partnership (SNP) announced the ... Heart Healthy: A Cardiovascular Risk Reduction Program for ... women understand and mitigate their risk of heart ... to Action, a plan for addressing significant global ...
(Date:9/22/2014)... Burbank, CA (PRWEB) September 22, 2014 ... social and mobile recruiting, announced today an ... talent management solutions for the healthcare industry. ... to TweetMyJobs’ suite of social recruiting solutions ... management software designed specifically for healthcare organizations. ...
(Date:9/22/2014)... MAINE AND BOSTON -- In a collaboration that ... advance cancer research and patient care and accelerate ... Beth Israel Deaconess Medical Center (BIDMC) have established ... institutions, presidents announced today. , A recently signed ... Center to establish a comprehensive relationship in the ...
(Date:9/22/2014)... NCPDP, the not-for-profit pharmacy standards development ... 2014 Educational Summit , “Improving the Infrastructure for ... 11, 2014 at the Hyatt Regency Indianapolis. Steven ... Technology, Office of the National Coordinator for Health ... takes place right before NCPDP’s Work Group Meetings, ...
Breaking Medicine News(10 mins):Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 2Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 4Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 2Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 3Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 4Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 2Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 3Health News:NCPDP Educational Summit, Improving the Infrastructure for Continuity of Care, Features Keynote, Steven Posnack 2Health News:NCPDP Educational Summit, Improving the Infrastructure for Continuity of Care, Features Keynote, Steven Posnack 3
... Mary Bono Mack (CA-45) and Nita Lowey (NY-18) ... and well-being of American youth by reintroducing the ... The bipartisan legislation, broadly supported by such organizations ... cross-sector collaboration for improving the health of young ...
... (Nasdaq: MDTH ), (the "Company") a healthcare ... and treatment of cardiovascular disease, today announced that it has ... quarter ended March 31, 2009 and the filing of its ... as a result of an ongoing internal assessment by the ...
... nation,s leading cardioelectrophysiologists, has joined The Mount Sinai Medical Center as ... ... (Vocus)-- Vivek Y. Reddy, M.D., one of the nation,s leading cardioelectrophysiologists, ... of Electrophysiology Laboratories. His appointment becomes effective July 1., , ...
... C. Kolars, M.D., has been named the University ... for Education and Global Initiatives, effective June 1, pending the ... the Medical School,s lead for the oversight and expansion of ... James O. Woolliscroft , M.D., the medical school,s ...
... Fund now has within its reach the potential to ... meeting in Geneva, the Board of Directors of the ... Fund), today agreed to enhance the Fund,s response to ... prevent mother-to-child transmission of HIV (PMTCT), thereby opening the ...
... of the Clopidogrel Medco Outcomes Study presented today during SCAI,s ... may be reduced when taken concurrently with commonly used heartburn ... patients taking clopidogrel and a PPI experienced a: , ... 50% increase in the combined risk of hospitalization for heart ...
Cached Medicine News:Health News:Bono Mack, Lowey Introduce Bill To Improve the Health of Youth 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 3Health News:Joseph C. Kolars, M.D., to be U-M Medical School's First Senior Associate Dean for Education and Global Initiatives 2Health News:GAA Applauds Global Fund's Decision to Accelerate Support for Treatment Strategies to Prevent Mother-to-Child Transmission of HIV 2Health News:SCAI Statement on 'A National Study of the Effect of Individual Proton Pump Inhibitors on Cardiovascular Outcomes in Patients Treated with Clopidogrel Following Coronary Stenting: The Clopidogrel Medco Outcomes Study' 2
... to 17 parameters from just 95 ... blood gases, as well as any ... metabolite parameters. Unique technology reduces to ... substances have on the accuracy of ...
... a sophisticated whole blood analysis system that ... also satisfying the stringent requirements of the ... contains all of the components of a ... the sampling unit, all of the sensors ...
... The Rapidlab 800 System is a ... key critical care whole blood parameters in ... modular design allows the basic blood gas ... to include electrolytes, metabolites and CO-oximetry in ...
This compact, easy-to-operate analyzer delivers basic blood gas, ISEs with direct measured total hemoglobin and saturated oxygen. Use it as a cost effective backup for the central lab or for remote p...
Medicine Products: